company background image
TLRY logo

Tilray Brands NasdaqGS:TLRY Stock Report

Last Price

US$1.92

Market Cap

US$1.5b

7D

0.5%

1Y

13.6%

Updated

22 Jul, 2024

Data

Company Financials +

TLRY Stock Overview

Engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

TLRY fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Tilray Brands, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tilray Brands
Historical stock prices
Current Share PriceUS$1.92
52 Week HighUS$3.40
52 Week LowUS$1.60
Beta2.2
11 Month Change15.66%
3 Month Change4.35%
1 Year Change13.61%
33 Year Change-85.99%
5 Year Changen/a
Change since IPO-88.07%

Recent News & Updates

Tilray Should Be Cut From Your Portfolio

Jul 14

Recent updates

Tilray Should Be Cut From Your Portfolio

Jul 14

Why Bears Think Tilray Brands Will Continue To Dip

May 29

Tilray Takes A Step Forward

May 21

An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 34% Undervalued

May 01
An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 34% Undervalued

Tilray Could Break Down

Apr 07

Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Climb 31% But Its Business Is Yet to Catch Up

Mar 27
Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Climb 31% But Its Business Is Yet to Catch Up

Tilray: Big Opportunities Ahead In Germany And Alcohol Segment

Mar 12

Tilray Brands (NASDAQ:TLRY) Is Carrying A Fair Bit Of Debt

Jan 25
Tilray Brands (NASDAQ:TLRY) Is Carrying A Fair Bit Of Debt

Tilray Remains Stuck In Neutral

Jan 10

Tilray Brands, Inc.'s (NASDAQ:TLRY) Price Is Right But Growth Is Lacking

Dec 19
Tilray Brands, Inc.'s (NASDAQ:TLRY) Price Is Right But Growth Is Lacking

Industry Analysts Just Upgraded Their Tilray Brands, Inc. (NASDAQ:TLRY) Revenue Forecasts By 13%

Oct 10
Industry Analysts Just Upgraded Their Tilray Brands, Inc. (NASDAQ:TLRY) Revenue Forecasts By 13%

Analysts Are Upgrading Tilray Brands, Inc. (NASDAQ:TLRY) After Its Latest Results

Oct 06
Analysts Are Upgrading Tilray Brands, Inc. (NASDAQ:TLRY) After Its Latest Results

Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 22% Below Their Intrinsic Value Estimate

Sep 18
Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 22% Below Their Intrinsic Value Estimate

Little Excitement Around Tilray Brands, Inc.'s (NASDAQ:TLRY) Revenues

Apr 17
Little Excitement Around Tilray Brands, Inc.'s (NASDAQ:TLRY) Revenues

An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 28% Undervalued

Feb 03
An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 28% Undervalued

Shareholder Returns

TLRYUS PharmaceuticalsUS Market
7D0.5%-2.9%-1.1%
1Y13.6%17.2%20.0%

Return vs Industry: TLRY underperformed the US Pharmaceuticals industry which returned 17.2% over the past year.

Return vs Market: TLRY underperformed the US Market which returned 20% over the past year.

Price Volatility

Is TLRY's price volatile compared to industry and market?
TLRY volatility
TLRY Average Weekly Movement13.8%
Pharmaceuticals Industry Average Movement9.9%
Market Average Movement5.9%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

Stable Share Price: TLRY's share price has been volatile over the past 3 months.

Volatility Over Time: TLRY's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a1,600Irwin Simonwww.tilray.com

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products.

Tilray Brands, Inc. Fundamentals Summary

How do Tilray Brands's earnings and revenue compare to its market cap?
TLRY fundamental statistics
Market capUS$1.48b
Earnings (TTM)-US$351.95m
Revenue (TTM)US$743.25m

2.1x

P/S Ratio

-4.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TLRY income statement (TTM)
RevenueUS$743.25m
Cost of RevenueUS$521.77m
Gross ProfitUS$221.48m
Other ExpensesUS$573.42m
Earnings-US$351.95m

Last Reported Earnings

Feb 29, 2024

Next Earnings Date

Jul 29, 2024

Earnings per share (EPS)-0.43
Gross Margin29.80%
Net Profit Margin-47.35%
Debt/Equity Ratio12.1%

How did TLRY perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.